Rockville, MD, United States of America

Nancy A Sharkey

This inventor holds 1 USPTO granted patent. Top assignees: Brigham Young University, The United States of America as Represented by the Department of Health. Active years: 1997.


% Patents Active = 100.0

Average Co-Inventor Count = 11.0

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 1997

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Nancy A. Sharkey

Introduction

Nancy A. Sharkey is a notable inventor based in Rockville, MD (US). She has made significant contributions to the field of antiviral therapies. Her work focuses on developing compositions that can effectively treat viral infections while minimizing adverse effects.

Latest Patents

Nancy A. Sharkey holds a patent for an antiviral composition. This invention relates to a formulation that includes prostratin, a phorbol ester derivative, combined with a pharmaceutically acceptable carrier. The composition is designed to exhibit antiviral activity without substantial tumor-promoting effects or other toxicological properties that could hinder its use in therapy.

Career Highlights

Throughout her career, Nancy has worked with esteemed organizations, including the United States of America as represented by the Department of Health and Brigham Young University. Her research has contributed to advancements in antiviral treatments, showcasing her dedication to improving public health.

Collaborations

Nancy has collaborated with notable individuals in her field, including Junichi Ishitoya and Peter M. Blumberg. These partnerships have enhanced her research and expanded the impact of her inventions.

Conclusion

Nancy A. Sharkey's innovative work in antiviral compositions highlights her commitment to advancing medical science. Her contributions are vital in the ongoing fight against viral infections, and her patent reflects her dedication to improving therapeutic options.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…